|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||
| Investments: | ||||||||||||||||
| Fixed maturity securities, available-for-sale, at fair value (amortized cost: March 31, 2019 - $21,908; December 31, 2018 - $22,219) | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total fixed maturity securities, available-for-sale, at fair value (amortized cost: March 31, 2019 - $21,908; December 31, 2018 - $22,219) | ||||||||||||||||
| Equity securities, available-for-sale, at fair value (amortized cost: December 31, 2017 - $764; September 30, 2017 - $733; September 30, 2016 - $640) | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total equity securities, available-for-sale, at fair value (amortized cost: December 31, 2017 - $764; September 30, 2017 - $733; September 30, 2016 - $640) | ||||||||||||||||
| Fixed maturity securities, available-for-sale, at fair value (amortized cost: March 31, 2020 - $22,836; December 31, 2019 - $22,914 and allowance for expected credit losses: March 31, 2020 - $44; December 31, 2019 - $0) | ||||||||||||||||
| Equity securities, at fair value (cost: March 31, 2020 - $1,052; December 31, 2019 - $1,069) | ||||||||||||||||
| Derivative investments, at fair value | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total derivative investments, at fair value | ||||||||||||||||
| Short term investments | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total short term investments | ||||||||||||||||
| Mortgage loans (allowance for expected credit losses: March 31, 2020 - $12; December 31, 2019 - $0) | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total mortgage loans (allowance for expected credit losses: March 31, 2020 - $12; December 31, 2019 - $0) | ||||||||||||||||
| Other invested assets | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total other invested assets | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total investments | ||||||||||||||||
| Related party loans | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total related party loans | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||
| Prepaid expenses | ||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||
| Total current assets | ||||||||||||||||
| Investments and cash equivalents held in Trust Account | ||||||||||||||||
| Accrued investment income | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total accrued investment income | ||||||||||||||||
| Funds withheld for reinsurance receivables, at fair value | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total funds withheld for reinsurance receivables, at fair value | ||||||||||||||||
| Reinsurance recoverable (allowance for expected credit losses: March 31, 2020 - $22; December 31, 2019 - $0) | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total reinsurance recoverable (allowance for expected credit losses: March 31, 2020 - $22; December 31, 2019 - $0) | ||||||||||||||||
| Intangibles, net | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total intangibles, net | ||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total deferred tax assets, net | ||||||||||||||||
| Goodwill | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total goodwill | ||||||||||||||||
| Other assets | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total other assets | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total assets | ||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||
| Accounts payable - related party | ||||||||||||||||
| Accrued commitment fee | ||||||||||||||||
| Due to related parties | ||||||||||||||||
| Total current liabilities | ||||||||||||||||
| Deferred underwriting commissions and placement agent fees | ||||||||||||||||
| Contractholder funds | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total contractholder funds | ||||||||||||||||
| Future policy benefits, including $1,904 and $1,953 at fair value at March 31, 2020 and December 31, 2019, respectively | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total future policy benefits, including $1,904 and $1,953 at fair value at March 31, 2020 and December 31, 2019, respectively | ||||||||||||||||
| Funds Held under Reinsurance Agreements, Liability | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total funds Held under Reinsurance Agreements, Liability | ||||||||||||||||
| Liability for policy and contract claims | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total liability for policy and contract claims | ||||||||||||||||
| Debt Instrument, Face Amount | ||||||||||||||||
| Debt | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total debt | ||||||||||||||||
| Revolving credit facility | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total revolving credit facility | ||||||||||||||||
| Deferred tax liability, net | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total deferred tax liability, net | ||||||||||||||||
| Other liabilities | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total other liabilities | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 62,337,495 and 64,066,643 shares at September 30, 2017 and December 31, 2016, respectively | ||||||||||||||||
| Shareholders' equity: | ||||||||||||||||
| Preferred stock ($.0001 par value, 100,000,000 shares authorized, 437,841 and 429,789 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively) | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total preferred stock ($.0001 par value, 100,000,000 shares authorized, 437,841 and 429,789 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively) | ||||||||||||||||
| Common stock ($.0001 par value, 800,000,000 shares authorized, 221,972,605 and 221,807,598 issued and outstanding at March 31, 2020 and December 31, 2019, respectively | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total common stock ($.0001 par value, 800,000,000 shares authorized, 221,972,605 and 221,807,598 issued and outstanding at March 31, 2020 and December 31, 2019, respectively | ||||||||||||||||
| Additional paid-in capital | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total additional paid-in capital | ||||||||||||||||
| Retained earnings (Accumulated deficit) | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total retained earnings (Accumulated deficit) | ||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total accumulated other comprehensive income (loss) | ||||||||||||||||
| Treasury Stock, Value | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total treasury Stock, Value | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total shareholders' equity | ||||||||||||||||
| Predecessor | ||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||
Loading...
